Last reviewed · How we verify
NCT04236882
Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African Americans
NA trial testing Focus Group in Behavioral Disorder in 28 participants. Participants enrolled and being followed up; not accepting new ones.
30 April 2030
Quick facts
| Lead sponsor | M.D. Anderson Cancer Center |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 28 |
| Start date | 4 October 2019 |
| Primary completion | 30 April 2030 |
| Estimated completion | 30 April 2030 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Focus Group
- Health Education
- Internet-Based Intervention
- Internet-Based Intervention
- Internet-Based Intervention
- Interview
- Questionnaire Administration
Conditions studied
- Behavioral Disorder — all drugs for Behavioral Disorder →
- Endocrine System Disorder — all drugs for Endocrine System Disorder →
Sponsor
M.D. Anderson Cancer Center — full company profile →
Who can join
Adults 21 to 65, any sex, with Behavioral Disorder or Endocrine System Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial studies how well sleep and physical activity interventions work in increasing the physical activity of overweight or obese and sedentary African Americans. Sleep and physical activity interventions may help to increase physical activity among overweight and obese African American adults who do not get enough exercise.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04236882
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Focus Group
Trials testing the same drug.
- NCT06786104 — Video Inspired Discussions About Ethical Outcomes in Pediatrics · NA · not yet recruiting
- NCT07049757 — Healthy Family Project: Tobacco Use and Smoke Exposure in Asian American Communities · NA · recruiting
- NCT06432985 — Smoking Cessation CM for Veterans With or at Risk for Cancer · NA · recruiting
- NCT06549153 — ACT-Together (Acting on Cancer Testing-Together) · NA · active not recruiting
- NCT06559462 — Nudge Strategies for DPYD Testing in Patients With Gastrointestinal Cancers Treated With Fluoropyrimidines · NA · completed
Other recruiting trials for Behavioral Disorder
Currently open trials in the same condition.
- NCT06852443 — Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT) · NA · recruiting
Other M.D. Anderson Cancer Center trials
Trials by the same sponsor.
- NCT07053020 — A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukem · Phase 1, PHASE2 · not yet recruiting
- NCT07052994 — A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and · Phase 1 · not yet recruiting
- NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che · Phase 2 · not yet recruiting
- NCT07162480 — Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca · Phase 2 · not yet recruiting
- NCT07076498 — Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standar · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04236882 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by M.D. Anderson Cancer Center
- Last refreshed: 17 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04236882.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing